SXT Pharmaceuticals(US:SXTC) Jin Rong Jie·2025-08-13 15:58Core Viewpoint - Su Xuan Tang (SXTC) experienced a stock price increase of 6.18%, reaching $1.656 per share, with a total market capitalization of $19.2 million as of August 13 [1] Financial Performance - As of March 31, 2025, Su Xuan Tang reported total revenue of $1.7409 million, reflecting a year-on-year decrease of 9.73% [1] - The company's net profit attributable to shareholders was -$3.3037 million, showing a year-on-year decline of 6.62% [1] Company Overview - Su Xuan Tang Pharmaceutical Co., Ltd. is an innovative Chinese pharmaceutical company focused on the research, production, and sales of traditional Chinese medicine (TCM) pieces, particularly modern TCM pieces for direct oral consumption and infusion [1] - Traditional Chinese medicine pieces have been widely used in China for thousands of years [1]